These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Eyetech Study Group Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845 [TBL] [Abstract][Full Text] [Related]
27. Strand and Cell Type-specific Function of microRNA-126 in Angiogenesis. Zhou Q; Anderson C; Hanus J; Zhao F; Ma J; Yoshimura A; Wang S Mol Ther; 2016 Oct; 24(10):1823-1835. PubMed ID: 27203443 [TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in laser-induced choroidal neovascularization in mice and rats: their expression and potential therapeutic targets. Martinez B; Peplow PV Neural Regen Res; 2021 Apr; 16(4):621-627. PubMed ID: 33063711 [TBL] [Abstract][Full Text] [Related]
29. PERK regulated miR-424(322)-503 cluster fine-tunes activation of IRE1 and ATF6 during Unfolded Protein Response. Gupta A; Hossain MM; Read DE; Hetz C; Samali A; Gupta S Sci Rep; 2015 Dec; 5():18304. PubMed ID: 26674075 [TBL] [Abstract][Full Text] [Related]
30. Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident Microglia. Yan L; Lee S; Lazzaro DR; Aranda J; Grant MB; Chaqour B J Biol Chem; 2015 Sep; 290(38):23264-81. PubMed ID: 26242736 [TBL] [Abstract][Full Text] [Related]
31. Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization. De Rossi G; Vähätupa M; Cristante E; Arokiasamy S; Liyanage SE; May U; Pellinen L; Uusitalo-Järvinen H; Bainbridge JW; Järvinen TAH; Whiteford JR Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1374-1389. PubMed ID: 33596666 [TBL] [Abstract][Full Text] [Related]
32. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice. Kim KL; Suh W Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845 [TBL] [Abstract][Full Text] [Related]
33. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization. Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818 [TBL] [Abstract][Full Text] [Related]
34. AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization. Tu L; Wang JH; Barathi VA; Prea SM; He Z; Lee JH; Bender J; King AE; Logan GJ; Alexander IE; Bee YS; Tai MH; Dusting GJ; Bui BV; Zhong J; Liu GS Angiogenesis; 2018 Feb; 21(1):95-109. PubMed ID: 29318471 [TBL] [Abstract][Full Text] [Related]
35. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization. Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943 [TBL] [Abstract][Full Text] [Related]
36. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases. Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278 [TBL] [Abstract][Full Text] [Related]
37. The 106b∼25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice. Semo J; Sharir R; Afek A; Avivi C; Barshack I; Maysel-Auslender S; Krelin Y; Kain D; Entin-Meer M; Keren G; George J Eur Heart J; 2014 Dec; 35(45):3212-23. PubMed ID: 23420866 [TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration. Cloutier F; Lawrence M; Goody R; Lamoureux S; Al-Mahmood S; Colin S; Ferry A; Conduzorgues JP; Hadri A; Cursiefen C; Udaondo P; Viaud E; Thorin E; Chemtob S Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1195-203. PubMed ID: 22323484 [TBL] [Abstract][Full Text] [Related]
39. Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder. Dong LF; Yao J; Wang XQ; Shan K; Yang H; Yan B; Jiang Q Biochem Biophys Res Commun; 2015 Oct; 465(4):678-84. PubMed ID: 26255966 [TBL] [Abstract][Full Text] [Related]
40. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis. Mammadzada P; Gudmundsson J; Kvanta A; André H Acta Ophthalmol; 2016 Dec; 94(8):805-814. PubMed ID: 27255568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]